Jfs Wealth Advisors, LLC Abb Vie Inc. Transaction History

Jfs Wealth Advisors, LLC

$1.49 Billion
Q3 2024

A detailed history of Jfs Wealth Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Jfs Wealth Advisors, LLC holds 10,182 shares of ABBV stock, worth $1.78 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

10,182

Previous 1,521 569.43%

Holding current value

$1.78 Million

Previous $260,000 673.08%

% of portfolio

0.14%

Previous 0.02%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	BUY	$163.84 - $199.33 $1.42 Million - $1.73 Million	8,661 Added 569.43%	10,182 $2.01 Million
Q2 2024 Jul 15, 2024	SELL	$154.79 - $180.76 $22,599 - $26,390	-146 Reduced 8.76%	1,521 $260,000
Q1 2024 Apr 30, 2024	SELL	$159.82 - $182.1 $21,096 - $24,037	-132 Reduced 7.34%	1,667 $303,000
Q4 2023 Feb 07, 2024	BUY	$137.6 - $154.97 $11,971 - $13,482	87 Added 5.08%	1,799 $278,000
Q3 2023 Nov 02, 2023	BUY	$133.59 - $154.65 $35,935 - $41,600	269 Added 18.64%	1,712 $255,000
Q2 2023 Aug 07, 2023	SELL	$132.51 - $164.9 $11,925 - $14,841	-90 Reduced 5.87%	1,443 $194,000
Q1 2023 Apr 19, 2023	SELL	$144.61 - $166.54 $48,733 - $56,123	-337 Reduced 18.02%	1,533 $244,000
Q4 2022 Feb 13, 2023	SELL	$138.31 - $165.87 $9,543 - $11,445	-69 Reduced 3.56%	1,870 $302,000
Q3 2022 Oct 21, 2022	SELL	$134.21 - $153.93 $8,723 - $10,005	-65 Reduced 3.24%	1,939 $260,000
Q2 2022 Aug 02, 2022	BUY	$137.62 - $174.96 $26,285 - $33,417	191 Added 10.54%	2,004 $307,000
Q1 2022 May 02, 2022	BUY	$131.98 - $163.75 $28,507 - $35,370	216 Added 13.53%	1,813 $294,000
Q4 2021 Feb 03, 2022	BUY	$107.43 - $135.93 $33,410 - $42,274	311 Added 24.18%	1,597 $216,000
Q3 2021 Nov 09, 2021	BUY	$106.4 - $120.78 $41,070 - $46,621	386 Added 42.89%	1,286 $139,000
Q2 2021 Aug 04, 2021	BUY	$105.21 - $117.21 $631 - $703	6 Added 0.67%	900 $101,000
Q1 2021 Apr 28, 2021	SELL	$102.3 - $112.62 $45,421 - $50,003	-444 Reduced 33.18%	894 $97,000
Q4 2020 Feb 01, 2021	BUY	$80.49 - $108.67 $34,288 - $46,293	426 Added 46.71%	1,338 $143,000
Q3 2020 Oct 28, 2020	BUY	$85.91 - $100.83 $85 - $100	1 Added 0.11%	912 $80,000
Q2 2020 Aug 05, 2020	SELL	$73.37 - $98.18 $293 - $392	-4 Reduced 0.44%	911 $89,000
Q1 2020 Apr 29, 2020	SELL	$64.5 - $97.79 $19,221 - $29,141	-298 Reduced 24.57%	915 $70,000
Q4 2019 Feb 03, 2020	BUY	$72.13 - $90.25 $5,914 - $7,400	82 Added 7.25%	1,213 $107,000
Q1 2019 Apr 23, 2019	SELL	$77.14 - $90.79 $2,699 - $3,177	-35 Reduced 3.0%	1,131 $91,000
Q4 2018 Jan 28, 2019	SELL	$77.85 - $96.01 $7,551 - $9,312	-97 Reduced 7.68%	1,166 $107,000
Q3 2018 Nov 09, 2018	BUY	$88.91 - $98.84 $7,290 - $8,104	82 Added 6.94%	1,263 $119,000
Q2 2018 Jul 26, 2018	BUY	$89.78 - $106.23 $1,167 - $1,380	13 Added 1.11%	1,181 $109,000
Q4 2017 Jan 31, 2018	BUY	$89.56 - $98.21 $3,313 - $3,633	37 Added 3.27%	1,168 $113,000
Q3 2017 Oct 20, 2017	BUY	$69.85 - $89.22 $79,000 - $100,907	1,131	1,131 $101,000

Others Institutions Holding ABBV

# of Institutions

3,855

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jfs Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jfs Wealth Advisors, LLC with notifications on news.

Account

Jfs Wealth Advisors, LLC Abb Vie Inc. Transaction History